Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 6/20 | 0.43 |
| ▸ | GHSR | Q92847 | 5/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.38 |
| ▸ | CTSS | P25774 | 1/20 | 0.37 |
| ▸ | KLK7 | P49862 | 2/20 | 0.36 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | MC4R | P32245 | 1/20 | 0.35 |
| ▸ | CCKBR | P32239 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5226011 | 0.89 | UGCG (0.44) | UGCGGHSRPPARACTSSCYP3A4 | |
| SCHEMBL5228528 | 0.86 | GHSR (0.53) | UGCGGHSRCYP3A4MC4RCCKBR | |
| SCHEMBL7671478 | 0.80 | PPARA (0.42) | UGCGGHSRPPARACTSSKLK7 | |
| SCHEMBL6832517 | 0.80 | GHSR (0.42) | UGCGGHSRPPARACTSSCYP3A4 | |
| SCHEMBL5226453 | 0.78 | GHSR (0.49) | UGCGGHSRPPARACTSSKLK7 | |
| SCHEMBL5225969 | 0.77 | GHSR (0.54) | UGCGGHSRCYP3A4MC4RCCKBR | |
| SCHEMBL5227517 | 0.75 | GHSR (0.62) | UGCGGHSRCYP3A4 | |
| SCHEMBL5226545 | 0.75 | GHSR (0.62) | UGCGGHSRCYP3A4 | |
| SCHEMBL5229910 | 0.75 | PLK1 (0.41) | — | |
| Hydrochloric Acid SCHEMBL7670267 | 0.74 | GHSR (0.61) | UGCGGHSRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030216399-A1 | Dipeptide derivatives | CARPINO PHILIP ALBERT (US) | 2003-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216399-A1 | Dipeptide derivatives | GIPR, GHRHR, GHSR | UGCG 2325/4885GHSR 3/4885PPARA 1854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.